2022年全球制药业CDMO调查（英）.pdf

2022 Global CDMO Study of Pharmaceutical Operations How to gain a competitive advantage in a fast- changing pharmaceutical supply ecosystem Contacts Germany Dr. Jens Neumann Holger Schmidt Dr. Malte Kremer Partner, Partner, Director, PwC Strategy Germany PwC Strategy Germany PwC Strategy Germany +49-172-2337-689 +49-170-2238-861 +49-160-9620-3714 jens.neumann@ holger.schmidt@ malte.kremer@ About the authors Dr. Jens Neumann is a Partner with Strategy, leading the Strategy Pharmaceutical and Life Sciences Operations platform across Europe. He has more than two decades of experience in advising Pharmaceutical and Life Sciences companies as well as contract development and manufacturing organizations on their operations and supply chain strategies and transformations. Additionally, he co-leads the Strategy manufacturing community and is an expert on digital operations strategies as well as biologics and advanced therapies. Dr. Sebastian Hölzl is a Senior Associate with Strategy Germany in the Pharma Life Science Operations platform based in Frankfurt am Main. His experience encompasses a wide range of operating model design and business development strategies. He advises pharmaceutical companies and contract development and manufacturing organizations as well as investment funds on their strategies. Dr. Friederike Laprell is a Senior Associate with Strategy Germany. Based in Hamburg, she is a member of the Pharma Life Science platform. She advises pharmaceutical companies as well as contract development and manufacturing organizations on their strategies. Her focus is on strategic and operational topics within biologics and advanced therapy manufacturing. EXECUTIVE SUMMARY The global Covid-19 pan